Rolf Müller

Prof. Dr. Rolf Müller is a Professor of Pharmaceutical Biotechnology at the Helmholtz-Institut für Pharmazeutische Forschung Saarland (HIPS), affiliated with the Faculty of Natural Sciences and Technology. His research group operates within the Department of Pharmaceutical Science, focusing on the discovery and development of biologically active natural products from microorganisms, especially myxobacteria.

The core of his research lies in understanding the molecular mechanisms behind the biosynthesis and regulation of secondary metabolites—compounds with significant therapeutic potential as antibiotics, anticancer agents, immunosuppressants, and antidiabetics. His group explores genetic and biochemical pathways involved in natural product formation, contributing to drug discovery and biotechnological innovation.

Key research initiatives include participation in the BMBF BioFuture competition, focusing on heterologous expression and modification of biosynthetic pathways, and involvement in the Sorangium Genome Project under the competence network for bacterial genome research relevant to agriculture, environment, and biotechnology. Additionally, the team works on the biotechnological production of bromelain, expanding their impact beyond microbial natural products.

Scientific awards and honors are not mentioned in the provided text.

Rolf Müller leads an active research group at HIPS, Campus E8.1 in Saarbrücken. While specific details about students or grants are not listed, his research is clearly aligned with industrial and pharmaceutical applications, supported by national research programs. His work integrates genomics, molecular biology, and biotechnology to unlock the pharmaceutical potential of understudied bacterial systems.